Corewell Health to adopt Abridge’s AI documentation tool

The deployment is one of Abridge’s largest health system partnerships, said CEO Shiv Rao. The product will be available to 4,000 employed physicians and advanced practice providers.

By Emily Olsen • Dec. 5, 2024

Risant Health completes acquisition of Cone Health

It’s the second of at least five planned buys for the Kaiser Permanente-backed nonprofit health system.

By Susanna Vogel • Dec. 4, 2024

Explore the Trendline➔

Payer/provider relationships

As M&A intensifies and companies embrace more holistic and value-based care models, partnerships have become more closely intertwined.

By Healthcare Dive staff

AI adoption for medical imaging soars: Klas Research

More than half of survey respondents reported using an AI algorithm for at least one imaging use case, compared with just 17% in 2018.

By Emily Olsen • Dec. 4, 2024

8 experts on leveraging AI in healthcare

Healthcare organizations must carefully vet AI tools, address patient concerns and keep an eye on standards and regulation, according to industry experts who spoke at a Healthcare Dive virtual event.

By Sydney Halleman • Dec. 3, 2024

Ascension reduces operating loss, grows volumes in Q1

The provider is rebounding from a sweeping cyberattack this spring that took its electronic health record offline for weeks and led to significant losses.

By Susanna Vogel • Dec. 3, 2024

Express Healthcare Staffing is the key to building exceptional patient care and compliance

As the demand for healthcare services surges, new solutions are necessary to meet worker demand.  

By Julie Neal • Dec. 2, 2024

Indiana health system withdraws merger application after regulator pushback

Union Health said it would submit a new Certificate of Public Advantage application to try to acquire Terre Haute Regional Hospital.

By Emily Olsen • Nov. 27, 2024

CHS deal to sell 3 Pennsylvania hospitals falls through after buyer fails to secure funds

Some lawmakers are concerned the facilities may close absent a deal.

By Susanna Vogel • Nov. 27, 2024

Sanofi joins J&J, Eli Lilly in proposing 340B rebate model

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top 10 drugs in global sales — early next year. It’s unclear how regulators will react.

By Rebecca Pifer • Updated Nov. 27, 2024

CHS to sell Florida-based ShorePoint Health System

The $265 million deal with AdventHealth is expected to close early next year.

By Susanna Vogel • Nov. 26, 2024

Hospital price transparency continues to drop: report

Just 21.1% of hospitals are in full compliance with federal price transparency rules, according to Patient Rights Advocate. Compliance has slipped since July 2023.

By Susanna Vogel • Nov. 22, 2024

Providers will need to boost cyber defenses amid AI adoption: Moody’s

AI could ease labor shortages, but health systems will need to increase cybersecurity spending to manage heightened risks, according to the credit ratings agency.

By Emily Olsen • Nov. 21, 2024

MPT installs new leadership at Prospect hospitals as system continues to miss rent payments

Prospect has attempted to sell hospitals to generate liquidity, but has been unable to offload several of its properties.

By Susanna Vogel • Updated Nov. 25, 2024

Providence names new COO

Darryl Elmouchi will take on the role effective Jan. 2 as Providence reshuffles its executive team.

By Susanna Vogel • Nov. 20, 2024

Eli Lilly follows J&J in suing Biden administration over 340B rebates

Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead of giving them upfront discounts on 340B drugs.

By Rebecca Pifer • Nov. 18, 2024

CHS is gearing up to play offense again in hospital M&A game, CFO says

The Franklin, Tennessee-based operator has not purchased a hospital in years. That may soon change as CHS' margins improve.

By Susanna Vogel • Nov. 15, 2024

Tenet CEO looks ahead to second Trump term

Saum Sutaria doesn't think the ACA marketplace is going anywhere under President-elect Donald Trump, noting beneficiaries are an “important part of the electorate” for the incoming administration.

By Susanna Vogel • Nov. 13, 2024

J&J sues federal government for halting 340B rebate plan

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.

By Rebecca Pifer • Nov. 13, 2024

High labor expenses still challenging providers: report

Medical groups' median investment in each employed physician surpassed $300,000 for the first time ever in the third quarter, according to Kaufman Hall.

By Emily Olsen • Nov. 13, 2024

Pharmacy costs, high utilization drive Kaiser to $608M operating loss in Q3

Kaiser said it would institute cost-cutting measures in response to the lackluster financial results, but didn’t detail specifics.

By Susanna Vogel • Nov. 12, 2024

Many hospitals still aren’t complying with price transparency rule: OIG

In a sample of 100 hospitals, 34 didn’t meet requirements for publishing machine-readable files of their charges while 14 didn’t follow rules to post shoppable services.

By Emily Olsen • Nov. 12, 2024

General Catalyst’s HATCo to acquire Summa Health for $485M

The deal, along with the Ohio-based health system’s current cash, would eliminate nearly all of Summa’s debt.

By Emily Olsen • Nov. 11, 2024

CHS to sell Mississippi hospital

Community Health Systems aims to net $1 billion or more in total proceeds from hospital sales.

By Susanna Vogel • Nov. 11, 2024

Ascension Michigan settles multiyear dispute about employee vaccination policy

The health system will offer up to five weeks of back pay to staff that were denied religious exemptions for COVID-19 vaccine mandates.

By Susanna Vogel • Nov. 7, 2024

How the healthcare industry is reacting to a second Trump term

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s how some of the most influential industry groups responded to the Republican’s reelection.

By Rebecca Pifer • Nov. 7, 2024